Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fulcrum Therapeutics (FULC) Return on Equity (2020 - 2025)

Historic Return on Equity for Fulcrum Therapeutics (FULC) over the last 6 years, with Q3 2025 value amounting to 0.26%.

  • Fulcrum Therapeutics' Return on Equity fell 1900.0% to 0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26%, marking a year-over-year decrease of 1900.0%. This contributed to the annual value of 0.04% for FY2024, which is 4100.0% up from last year.
  • Fulcrum Therapeutics' Return on Equity amounted to 0.26% in Q3 2025, which was down 1900.0% from 0.25% recorded in Q2 2025.
  • Over the past 5 years, Fulcrum Therapeutics' Return on Equity peaked at 0.07% during Q1 2025, and registered a low of 0.62% during Q1 2021.
  • In the last 5 years, Fulcrum Therapeutics' Return on Equity had a median value of 0.4% in 2023 and averaged 0.36%.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -3900bps in 2021, then skyrocketed by 5200bps in 2025.
  • Quarter analysis of 5 years shows Fulcrum Therapeutics' Return on Equity stood at 0.37% in 2021, then plummeted by -43bps to 0.52% in 2022, then rose by 24bps to 0.4% in 2023, then skyrocketed by 90bps to 0.04% in 2024, then tumbled by -566bps to 0.26% in 2025.
  • Its last three reported values are 0.26% in Q3 2025, 0.25% for Q2 2025, and 0.07% during Q1 2025.